SEC Form D · filed June 10, 2020
Larimar Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jonathan Leff · Bala Cynwyd, PADirectorCarole Ben Maimon, Md · Bala Cynwyd, PAExec · DirectorThomas O. Daniel · Bala Cynwyd, PADirectorJoseph Truitt · Bala Cynwyd, PADirectorMichael Celano · Bala Cynwyd, PAExecFrank E. Thomas · Bala Cynwyd, PADirectorThomas Hamilton · Bala Cynwyd, PADirectorPeter Barrett · Bala Cynwyd, PADirectorMichael Wahl · Brookline, MADirectorKatie Mcclain · Chicago, ILDirectorAnshuman Vohra · New York, NYExecRob Soni · New York, NYDirectorSignalfire Vss I GP, L.L.C · SAN FRANCISCO, CADirectorHomayar Gandhi · Irvine, CAExec · DirectorBrant Brown · Dallas, TXDirectorKyle Jameson · Lexington, KYDirectorMichael Hiles · Cincinnati, OHDirectorRobert Slater · Cincinnati, OHDirectorJohn Bentley · Cincinnati, OHDirectorNiall C. Mccomiskey · Rye, NYExecMichael C. Weiss · Rye, NYDirectorRoss H. Bierkan · Vienna, VAExec · DirectorThomas R. Burbon · Baltimore, MDDirectorLawrence E. Collins · Baltimore, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗